Uncategorized
Visus Therapeutics Hosts Inaugural Capital Markets Day in New York City
SEATTLE--(BUSINESS WIRE)--Visus Therapeutics Inc., a clinical-stage pharmaceutical company focused on developing innovative ophthalmic therapies to improve vision for people around the world, recently welcomed investors, analysts and media to its inaugural Capital Markets Day in New York City. Visus Therapeutics’ management team and some of the world’s leading eye care experts presented new information on the company’s lead asset, BRIMOCHOL™, an investigational drug designed to be a once-daily